288 related articles for article (PubMed ID: 32096127)
1. Dermatomyositis: An Update on Diagnosis and Treatment.
Cobos GA; Femia A; Vleugels RA
Am J Clin Dermatol; 2020 Jun; 21(3):339-353. PubMed ID: 32096127
[TBL] [Abstract][Full Text] [Related]
2. Dermatomyositis: Diagnosis and treatment.
Waldman R; DeWane ME; Lu J
J Am Acad Dermatol; 2020 Feb; 82(2):283-296. PubMed ID: 31279813
[TBL] [Abstract][Full Text] [Related]
3. A case of dermatomyositis with the anti-signal recognition particle antibody that was successfully treated with prednisolone and intravenous immunoglobulin therapy.
Mizumaki K; Maeda S; Ikawa Y; Matsushita T; Takehara K; Hamaguchi Y
J Dermatol; 2019 Jul; 46(7):e251-e253. PubMed ID: 30690762
[No Abstract] [Full Text] [Related]
4. Dermatomyositis: Clinical features and pathogenesis.
DeWane ME; Waldman R; Lu J
J Am Acad Dermatol; 2020 Feb; 82(2):267-281. PubMed ID: 31279808
[TBL] [Abstract][Full Text] [Related]
5. Management of cutaneous dermatomyositis: current therapeutic options.
Quain RD; Werth VP
Am J Clin Dermatol; 2006; 7(6):341-51. PubMed ID: 17173468
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
Dourmishev LA
Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
[TBL] [Abstract][Full Text] [Related]
7. [Dermatomyositis].
Sugie K
Brain Nerve; 2024 May; 76(5):635-645. PubMed ID: 38741507
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.
Mainetti C; Terziroli Beretta-Piccoli B; Selmi C
Clin Rev Allergy Immunol; 2017 Dec; 53(3):337-356. PubMed ID: 29090371
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous signs of classical dermatomyositis.
Auriemma M; Capo A; Meogrossi G; Amerio P
G Ital Dermatol Venereol; 2014 Oct; 149(5):505-17. PubMed ID: 25014587
[TBL] [Abstract][Full Text] [Related]
10. Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.
Wienke J; Deakin CT; Wedderburn LR; van Wijk F; van Royen-Kerkhof A
Front Immunol; 2018; 9():2951. PubMed ID: 30619311
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
[TBL] [Abstract][Full Text] [Related]
12. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
Cherin P
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
[TBL] [Abstract][Full Text] [Related]
13. Nuclear matrix protein 2 antibody-positive adult dermatomyositis: a case report and review of the literature.
Cartron AM; Osler M; Chung C; Trinidad JC
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609448
[TBL] [Abstract][Full Text] [Related]
14. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.
Mammen AL
Ann N Y Acad Sci; 2010 Jan; 1184():134-53. PubMed ID: 20146695
[TBL] [Abstract][Full Text] [Related]
15. Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis.
Kasteler JS; Callen JP
J Am Acad Dermatol; 1997 Jan; 36(1):67-71. PubMed ID: 8996263
[TBL] [Abstract][Full Text] [Related]
16. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
Dalakas MC
J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
[TBL] [Abstract][Full Text] [Related]
17. Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy.
Monseau G; Landon-Cardinal O; Stenzel W; Schoindre Y; Mariampillai K; Barete S; Martel C; Masseau A; Meyer A; Terrier B; Guégan S; Verneuil L; Audia S; Livideanu CB; Hachulla E; Kahn JE; Lefevre G; Maurier F; Moulis G; Papo T; Dossier A; Descamps V; Salort-Campana E; Richard MA; Bergot E; Mortier L; Costedoat-Chalumeau N; Genot S; Perez F; Piette AM; Samson M; Schleinitz N; Zénone T; Lacoste M; de Boysson H; Madaule S; Rigolet A; Champtiaux N; Hervier B; Bouvier AM; Jooste V; Léonard-Louis S; Maisonobe T; Aouba A; Benveniste O; Bienvenu B; Allenbach Y;
J Am Acad Dermatol; 2020 Dec; 83(6):1759-1763. PubMed ID: 32244015
[No Abstract] [Full Text] [Related]
18. Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.
Muro Y; Sugiura K; Akiyama M
Clin Rev Allergy Immunol; 2016 Dec; 51(3):293-302. PubMed ID: 26100618
[TBL] [Abstract][Full Text] [Related]
19. Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology.
Sunderkötter C; Nast A; Worm M; Dengler R; Dörner T; Ganter H; Hohlfeld R; Melms A; Melzer N; Rösler K; Schmidt J; Sinnreich M; Walter MC; Wanschitz J; Wiendl H
J Dtsch Dermatol Ges; 2016 Mar; 14(3):321-38. PubMed ID: 26972210
[TBL] [Abstract][Full Text] [Related]
20. [Dermatomyositis and polymyositis: clinical aspects and treatment].
Hachulla E
Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
